Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs
Provided By PR Newswire
Last update: May 6, 2025
EMERYVILLE, Calif., May 6, 2025 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today reported financial results and provided a business update for the quarter ended March 31, 2025.
Read more at prnewswire.com
